Innovus Pharmaceuticals Inc. (fka INNV)

[sweetstreet]

Good points...wondering how you're arriving at $30M being aggressive with approval of the original ANDA. The West-Ward ANDA is to give INNV $10-15M first year. Keep in mind that $10-15M is a gross understatement of Fluticare penetration versus a scenario where the original ANDA is approved. West-Ward wants to optimize product mix to avoid cannibalizing sales of store brand fluticasone propionate. That means they have to cap their sales to INNV. With the original ANDA being approved, INNV no longer faces the same supply constraints, and we get to see how well Fluticare brand equity truly transfers over from prescription.